Safety and Efficacy of Cladribine Therapy After Anti CD20 Therapy

Clinical trial NCT04640818 · UNKNOWN

Trial details

NCT number: NCT04640818
Sponsor: Claudio Gobbi
Status: UNKNOWN
Study type: OBSERVATIONAL

Multiple Sclerosis

Start date: 2020-12-17
Primary completion: 2022-10-31
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.